MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› If you often need to get online when there’s no Wi-Fi around and your phone’s hotspot ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› by Anna Wenner Denture adhesives can provide extra security, especially when eating tough ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

Abstract: The mechanical properties of the Ti-6Al-4V alloy make it a promising material for high-temperature applications. However, uncertainties surround the long-term performance and reliability of ...

By Steve Neavling President Trump on Monday signed an executive order designating illicit fentanyl as a weapon of mass destruction, a move that expands the role of the Pentagon and Justice Department ...

Learn more about the MS Emerging Markets Debt (MSD: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you stay up ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.